Pancreatic cancer is the sixth leading cause of cancer death in Hong Kong, accounting for approximately 500 cancer deaths every year and occurs at around the age of 70. Known as the deadliest type of cancer, pancreatic cancer has the highest mortality rate of all the major cancers, far exceeding that of lung and colorectal cancer.
It has drawn a substantial amount of attention around the world as a global medical challenge. According to the latest statistics published by the Cancer Council of Australia, the five-year survival rate for pancreatic cancer is only 7%, and approximately 30% of deaths occur just two months following diagnosis. Over 80% of pancreatic cancer patients are diagnosed with cases of advanced pancreatic cancer that are inoperable.
In the past ten years, a number of international medical studies have recognized the therapeutic potential of a new pancreatic cancer treatment option called stereotactic body radiation therapy (SBRT) that improves the overall effectiveness of pancreatic cancer treatment. According to pancreatic cancer research from The University of Texas MD Anderson Cancer Center, SBRT has proven effective in shrinking pancreatic cancer tumours, with close to 90% of patients seeing their cancer tumours completely removed following surgery. This research is bringing new hope to pancreatic cancer treatments.
What follows below is the latest information about pancreatic cancer treatments and an overview of the treatment options, including FAQs regarding pancreatic cancer symptoms and treatment options from their diagnosis to their treatment.